IRIS
ETTARI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.929
NA - Nord America 5.991
AS - Asia 3.398
SA - Sud America 1.154
Continente sconosciuto - Info sul continente non disponibili 577
AF - Africa 117
OC - Oceania 2
AN - Antartide 1
Totale 18.169
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.762
RU - Federazione Russa 3.648
SG - Singapore 1.401
BR - Brasile 983
CN - Cina 928
IE - Irlanda 804
IT - Italia 768
SE - Svezia 601
HK - Hong Kong 403
VN - Vietnam 228
DE - Germania 203
FR - Francia 201
GB - Regno Unito 156
PL - Polonia 125
IN - India 110
UA - Ucraina 108
FI - Finlandia 103
CA - Canada 100
AT - Austria 78
BD - Bangladesh 64
AR - Argentina 51
MX - Messico 48
IQ - Iraq 37
TR - Turchia 33
BE - Belgio 30
MA - Marocco 30
ZA - Sudafrica 30
ID - Indonesia 29
NL - Olanda 29
EC - Ecuador 26
CO - Colombia 23
UZ - Uzbekistan 22
JP - Giappone 20
VE - Venezuela 20
ES - Italia 18
PK - Pakistan 17
UY - Uruguay 15
CR - Costa Rica 13
PY - Paraguay 13
SA - Arabia Saudita 13
TN - Tunisia 13
AE - Emirati Arabi Uniti 12
CL - Cile 10
CZ - Repubblica Ceca 10
TT - Trinidad e Tobago 10
GE - Georgia 9
JM - Giamaica 9
MY - Malesia 9
PR - Porto Rico 9
DZ - Algeria 8
NI - Nicaragua 8
SV - El Salvador 8
HN - Honduras 7
IL - Israele 7
LT - Lituania 7
PE - Perù 7
AZ - Azerbaigian 6
BO - Bolivia 6
CI - Costa d'Avorio 6
KE - Kenya 6
KZ - Kazakistan 6
PH - Filippine 6
DO - Repubblica Dominicana 5
EG - Egitto 5
ET - Etiopia 5
LB - Libano 5
SC - Seychelles 5
AL - Albania 4
BG - Bulgaria 4
CH - Svizzera 4
GR - Grecia 4
JO - Giordania 4
KG - Kirghizistan 4
LV - Lettonia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CW - ???statistics.table.value.countryCode.CW??? 3
EU - Europa 3
GP - Guadalupe 3
KR - Corea 3
KW - Kuwait 3
NP - Nepal 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
GA - Gabon 2
GT - Guatemala 2
MD - Moldavia 2
MU - Mauritius 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
AQ - Antartide 1
AU - Australia 1
DK - Danimarca 1
Totale 17.578
Salva come PNG Salva come JPEG
Città #
Moscow 1.058
Ashburn 903
Dublin 804
Singapore 742
Chandler 547
Nyköping 433
Hong Kong 402
Dallas 370
Beijing 343
San Jose 329
Messina 262
Jacksonville 231
Council Bluffs 211
The Dalles 134
Princeton 128
Warsaw 123
Medford 115
Lauterbourg 110
Los Angeles 106
Dearborn 91
Des Moines 91
Cambridge 81
São Paulo 74
Ann Arbor 71
Ho Chi Minh City 71
Vienna 71
New York 63
Buffalo 62
Santa Clara 59
Redondo Beach 51
Tianjin 48
Hanoi 47
Boardman 43
Montreal 36
Rome 35
Frankfurt am Main 34
Lancaster 34
Rio de Janeiro 33
Guangzhou 31
Munich 31
Jinan 30
San Mateo 30
Houston 29
Orem 28
Chicago 27
Hyderabad 25
Brussels 24
Atlanta 22
Belo Horizonte 22
Phoenix 22
Stockholm 21
Tashkent 21
Aversa 20
Brooklyn 20
Curitiba 20
San Francisco 20
Brasília 19
Milan 19
Seattle 19
Wilmington 19
Amsterdam 18
Tokyo 18
Mexico City 17
Baghdad 16
Campinas 16
Porto Alegre 16
Pune 16
North Bergen 15
Shanghai 15
Shenzhen 15
Catania 14
Columbus 14
Johannesburg 14
London 14
Shenyang 14
Bari 13
Chennai 13
Denver 13
Woodbridge 13
Boston 12
Düsseldorf 12
Montevideo 12
Montpellier 12
Mumbai 12
Naples 12
Newark 12
Palermo 12
Washington 12
Augusta 11
Casablanca 11
Taizhou 11
Dong Ket 10
Guarulhos 10
Haikou 10
Helsinki 10
Nanjing 10
Nuremberg 10
San José 10
Uberlândia 10
Zhengzhou 10
Totale 9.480
Salva come PNG Salva come JPEG
Nome #
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis 260
Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose–Effect Relationships in an Experimental In Vitro Model of Osteoarthritis 227
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 209
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 199
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 193
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 188
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 180
Drug combination studies of isoquinolinone AM12 with curcumin or quercetin: a new combination strategy to synergistically inhibit 20S proteasome 179
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 176
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 176
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 174
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 173
A novel benzodiazepine derivative that suppresses microtubule dynamics and impairs mitotic progression 172
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 168
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 168
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 168
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 168
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 166
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: Investigation of electronic effects 163
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 162
Design and synthesis of novel isoxazole-based HDAC inhibitors 161
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 161
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 161
Formation of 3-Aminofuran-2-(5H)-ones and 3-Amino-1H-pyrrole-2,5-diones by Rearrangement of Isoxazolidines 160
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 160
Development of novel amides as non covalent inhibitors of immunoproteasome 159
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: investigation of electronic effects 157
A novel 2,3-benzodiazepine-4-one derivative AMPA antagonist inhibits G2/M transition and induces apoptosis in human leukemia Jurkat T cell line 157
Evaluation of curcumin irreversibility 157
Falcipain-2 inhibitors 156
Composti antitumorali 156
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 156
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 154
Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications 152
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 152
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 150
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 150
Development of pyridin-2-one derivatives as non-covalent inhibitors of immunoproteasome 149
Role of the microbiota in hematologic malignancies. 149
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 148
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 148
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 146
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 145
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 144
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 142
Glutamate Binding-Site Ligands of NMDA Receptors 141
Blunting Neuroinflammation by Targeting the Immunoproteasome with Novel Amide Derivatives 140
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 140
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 139
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 137
Cross-metathesis reactions applications to the synthesis of peptidomimetics as potent falcipain-2 inhibitors 137
Development of novel peptide-based Michael acceptors as antitrypanosomal agents 137
A second opportunity for the peptide-based analogues with γ-lactam at the P1 position: human cathepsin S inhibition 134
Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense 134
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 133
Monoclonal antibodies: the greatest resource to treat multiple myeloma 131
Development of peptidomimetic boronates as proteasome inhibitors 130
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 130
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 130
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 130
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 130
Mechanism of Inhibition of the GluA2 AMPA Receptor Channel Opening: The Role of 4-Methyl versus 4-Carbonyl Group on the Diazepine Ring of 2,3-Benzodiazepine Derivatives 129
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 128
Development of peptidomimetic boronates as proteasome inhibitors 128
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 127
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 125
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 125
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 124
Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors 124
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 124
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC FALCIPAIN-2 INHIBITORS AS ANTIMALARIAL AGENTS 124
Drug repositioning for the treatment of hematologic disease: limits, challenges and future perspectives 123
Development of reduced peptide bond pseudopeptide Michael acceptors for the treatment of Human African Trypanosomiasis 123
A proteomic platform unveils the brain glycogen phosphorylase as a potential metabolic target for glioblastoma multiforme 122
Novel peptidomimetics as antiplasmodial falcipain-2 inhibitors 121
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 121
Discovery of novel antitrypanosomal agents: design, synthesis of novel benzodiazepine-based peptidomimetics targeting rhodesain, the main cysteine protease of Trypanosoma brucei rhodesiense 121
Synthesis and Molecular Modeling Studies of Derivatives of a Highly Potent Peptidomimetic Vinyl Ester as Falcipain-2 Inhibitors 121
Dipeptide nitrile CD34 with curcumin: a new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense 121
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 120
Reazioni di cross metathesis: applicazione alla sintesi di peptidomimetici potenziali inibitori di falcipaina-2 117
Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole. 117
Nonpeptidic Vinyl and Allyl Phosphonates as Falcipain-2 Inhibitors 116
Development of nonpeptidic vinyl and allyl phosphonates as active-site-directed inhibitors of falcipain-2 113
Recent Advances in Nanotherapeutics for Multiple Myeloma 112
Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents 111
Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment 110
Development of Peptidomimetics with a Vinyl Sulfone Warhead as Irreversible Falcipain-2 Inhibitors 109
Formaldehyde exposure and acute myeloid leukemia: A review of the literature 109
Development of novel amides as noncovalent inhibitors of immunoproteasome 107
Synthesis of constrained dipeptide mimics containing the benzodiazepine scaffold 105
Novel peptidomimetics containing a β-turn mimetic 1,4-Benzodiazepine scaffold as falcipain-2 inhibitors 105
Synthesis and anti-HIV activity evaluation of new phenyl ethyl thiourea (PET) derivatives 105
Identification of a new series of non-covalent proteasome inhibitors with selectivity for β5-subunits 103
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 103
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 103
Falcipain-2 and Falcipain-3 inhibitors as promising antimalarial agents 103
Novel Peptidomimetics Containing a Vinyl Ester Moiety as Highly Potent and Selective Falcipain-2 Inhibitors 102
Synthesis of Peptidomimetics with the Benzodiazepine Nucleus as beta-turn mimic 102
Mechanism and Site of Inhibition of AMPA Receptors: Substitution of One and Two Methyl groups at the 4-Aminophenyl Ring of 2,3-Benzodiazepine and Implications in the “E” Site 102
Totale 14.157
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022602 0 0 0 0 14 6 65 25 7 53 133 299
2022/20232.281 182 201 103 179 141 229 36 148 959 4 76 23
2023/2024589 69 72 41 143 55 48 6 8 3 62 33 49
2024/20252.463 41 21 44 157 92 56 75 460 676 175 236 430
2025/20268.358 306 531 538 656 689 1.792 1.082 1.054 1.018 366 134 192
2026/20271.617 143 396 464 530 84 0 0 0 0 0 0 0
Totale 18.169